QRX003, 4% Lotion Clinical Trials
2 recruitingDrug
Phase 22Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Netherton Syndrome
Quoin Pharmaceuticals8 enrolled1 locationNCT06953466
Recruiting
Phase 2Phase 3
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Netherton Syndrome
Quoin Pharmaceuticals20 enrolled4 locationsNCT05789056